Catalent Inc (CTLT)
56.50
+0.16
(+0.28%)
USD |
NYSE |
May 03, 16:00
56.50
0.00 (0.00%)
After-Hours: 20:00
Catalent 1 Year Total Returns (Daily): 15.68% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 15.68% |
May 02, 2024 | 15.64% |
May 01, 2024 | 11.73% |
April 30, 2024 | 11.43% |
April 29, 2024 | 12.33% |
April 26, 2024 | 27.88% |
April 25, 2024 | 31.73% |
April 24, 2024 | 24.50% |
April 23, 2024 | 24.43% |
April 22, 2024 | 24.47% |
April 19, 2024 | 28.81% |
April 18, 2024 | 32.60% |
April 17, 2024 | 23.18% |
April 16, 2024 | 20.42% |
April 15, 2024 | 21.07% |
April 12, 2024 | -12.37% |
April 11, 2024 | -13.02% |
April 10, 2024 | -15.22% |
April 09, 2024 | -12.22% |
April 08, 2024 | -12.72% |
April 05, 2024 | -7.90% |
April 04, 2024 | -8.50% |
April 03, 2024 | -9.92% |
April 02, 2024 | -14.09% |
April 01, 2024 | -14.18% |
Date | Value |
---|---|
March 28, 2024 | -14.37% |
March 27, 2024 | -16.34% |
March 26, 2024 | -12.46% |
March 25, 2024 | -12.25% |
March 22, 2024 | -13.70% |
March 21, 2024 | -16.37% |
March 20, 2024 | -16.57% |
March 19, 2024 | -16.63% |
March 18, 2024 | -16.61% |
March 15, 2024 | -19.50% |
March 14, 2024 | -19.36% |
March 13, 2024 | -13.81% |
March 12, 2024 | -16.81% |
March 11, 2024 | -16.36% |
March 08, 2024 | -19.03% |
March 07, 2024 | -16.89% |
March 06, 2024 | -20.59% |
March 05, 2024 | -23.30% |
March 04, 2024 | -23.31% |
March 01, 2024 | -17.13% |
February 29, 2024 | -15.95% |
February 28, 2024 | -15.07% |
February 27, 2024 | -13.44% |
February 26, 2024 | -14.25% |
February 23, 2024 | -13.13% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.94%
Minimum
Nov 03 2022
181.5%
Maximum
Mar 18 2021
14.77%
Average
17.90%
Median
Apr 01 2020
1 Year Total Returns (Daily) Benchmarks
Eli Lilly and Co | 71.87% |
Merck & Co Inc | 10.81% |
Elanco Animal Health Inc | 48.03% |
Amgen Inc | 40.32% |
Avrobio Inc | 83.40% |